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a  b  s  t  r  a  c  t
We  evaluated  whether  the short-term  use  of  dexmedetomidine  and  propofol  may  attenuate  inﬂam-
matory  response  and  improve  lung  morphofunction  in  experimental  acute  lung  injury (ALI).  Thirty-six
Wistar  rats  were  randomly  divided  into  ﬁve  groups.  Control  (C) and  ALI  animals  received sterile saline
solution  and  Escherichia  coli lipopolysaccharide  by intraperitoneal  injection  respectively.  After  24  h,  ALI
animals were  randomly  treated  with  dexmedetomidine,  propofol,  or thiopental  sodium  for  1 h. Propofol
reduced  static  lung  elastance  and  resistive  pressure  and  was  associated  with  less  alveolar  collapse  com-
pared to thiopental  sodium  and  dexmedetomidine.  Dexmedetomidine  improved  oxygenation,  but  did
not modify  lung mechanics  or histology.  Propofol  was  associated  with  lower  IL  (interleukin)-6  and  IL-ytokines. 1  expression,  whereas  dexmedetomidine  led  to reduced  inducible  nitric  oxide  (iNOS) and  increased
nuclear  factor  erythroid  2-related  factor  2  (Nrf2)  expression  in  lung  tissue  compared  to thiopental
sodium.  In conclusion,  in  this  model  of mild ALI,  short-term  use  of  dexmedetomidine  and  propo-
fol  led  to different  functional  effects  and  activation  of  biological  markers  associated  with  pulmonary
inﬂammation.
©  2014  Elsevier  B.V.  All  rights  reserved.. Introduction
Dexmedetomidine and propofol have been used for sedation
nd short-term surgical procedures in patients with acute respira-
ory distress syndrome (Choi, 2013; Iapichino et al., 2003; Jin et al.,
013). Dexmedetomidine has been reported to decrease inﬂamma-
ory response (Gu et al., 2011; Yang et al., 2009) through a reduction
n oxidative stress (Yang et al., 2011, 2008), whereas propofol
educes pulmonary inﬂammation (Chen et al., 2008; Yeh et al.,
011), oxidative stress (Chen et al., 2008; Tsao et al., 2008), and
poptosis (Kalimeris et al., 2011). The immunomodulatory capacity
∗ Corresponding author. Tel.: +5521 3938 6530; fax: +5521 2280 8193.
E-mail addresses: prmrocco@biof.ufrj.br, prmrocco@gmail.com (P.R.M. Rocco).
ttp://dx.doi.org/10.1016/j.resp.2014.08.008
569-9048/© 2014 Elsevier B.V. All rights reserved.of these agents has been investigated before (Gao et al., 2010; Xu
et al., 2013), at the moment of lung injury induction (Gu et al.,
2011; Yeh et al., 2011) and during long-term use (Chu et al., 2007;
Yang et al., 2008). Furthermore, their effects on lung inﬂammation
depend on timing (Chen et al., 2008; Taniguchi et al., 2008) and
length (Gao et al., 2010) of administration. So far, no study has eval-
uated their impact on lung morphofunction and molecular biology
during short-term use and after the establishment of acute lung
injury.
The aim of the present study was to analyze the effects of
dexmedetomidine and propofol on lung mechanics, histology, and
biological markers associated with pro- and anti-inﬂammatory
activities, ﬁbrogenesis, and oxidative stress in an experimental
model of mild acute lung injury during controlled mechanical
ventilation in rats.
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. Material and methods
This study was approved by the Research Ethics Committee
f the Federal University of Rio de Janeiro Health Sciences Cen-
re (CEUA 019). All animals received humane care in compliance
ith the “Principles of Laboratory Animal Care” formulated by
he National Society for Medical Research and the “Guide for the
are and Use of Laboratory Animals” prepared by the U.S. National
cademy of Sciences.
.1. Animal preparation and experimental protocol
Thirty-six female Wistar rats (weight 250–300 g) were used for
his study. Thirty rats received Escherichia coli lipopolysaccharide
LPS O55:B5), 1000 g suspended in saline solution to a total vol-
me  of 1000 l, by intraperitoneal injection (i.p.) (acute lung injury,
LI). Six rats received saline solution alone (1000 l, i.p.) and consti-
uted the control (C) group. Of the 30 ALI animals, 24 were allocated
cross three subgroups (n = 8/subgroup). These animals received
hiopental sodium (50 mg/kg, i.p.), underwent tail vein cannulation
ith a 24-gauge polyethylene catheter, and were then randomly
ssigned to receive: (a) thiopental sodium, 5 mg/kg/h by intra-
enous infusion; (b) dexmedetomidine, one 5-g  bolus over 10 min
ollowed by intravenous infusion at a rate of 0.5 g/kg/h; or (c)
ropofol by intravenous infusion, at a rate of 100–200 g/kg/min
or 10 min  and 75–100 g/kg/min thereafter. The infusion rates
f propofol and dexmedetomidine were based on previous stud-
es that reported a negligible effect of these anesthetic agents on
emodynamic parameters in septic animals (Chu et al., 2007; Gu
t al., 2011; Song et al., 2009; Yang et al., 2008). Additionally, these
nfusion rates were adopted to ensure a similar level of anesthe-
ia in all groups. Finally, the whole saline control (C) group (n = 6)
nd the remaining ALI animals not assigned to any of the three
reatment subgroups (n = 6) received thiopental sodium (50 mg/kg
.p.) and were assigned to non-ventilated (NV) groups (C-NV and
LI-NV, respectively) for lung morphometry and molecular biol-
gy analysis. C-NV and ALI-NV rats were euthanized 5 min  after
dministration of thiopental sodium so that this anesthetic agent
ould not affect molecular biology parameters.
During spontaneous breathing, the level of anesthesia was
ssessed by evaluating pupil size, position, and response to
ight, position of the nictitating membrane, and movement in
esponse to tail stimulation. When an appropriate plane of anes-
hesia had been achieved, tracheotomy was performed after
ocal anesthesia (lidocaine 1%, subcutaneously). A polyethylene
atheter (PE-10) was inserted into the carotid artery for blood
ampling and monitoring of mean arterial pressure (MAP). Elec-
rocardiogram (EKG) tracings, MAP, and rectal temperature were
ontinuously recorded (Networked Multi-Parameter Veterinary
onitor LifeWindowTM 6000V, Digicare Animal Health, Florida,
SA). Gelafundin® (B. Braun, Melsungen, Germany) was  admin-
stered (titrated in 0.5 ml  increments), if necessary, to maintain
AP  ≥70 mmHg. Pancuronium bromide was then administered
2 mg/kg in the tail vein) to maintain paralysis for 1 h, with an
dditional bolus equal to half of the initial dose whenever nec-
ssary. Lungs were mechanically ventilated (Servo-i, MAQUET,
olna, Sweden) in volume-controlled mode with tidal volume
VT) = 6 ml/kg, respiratory rate (RR) = 80 breaths/min, fraction of
nspired oxygen (FIO2) = 0.4, and zero end-expiratory pressure
ZEEP) during 5 min. Functional data (EKG, MAP, mechanics, and
ectal temperature) had been collected (Baseline-ZEEP) to eval-
ate whether lung mechanical impairment was similar in all ALI
roups at the beginning of the experiment. Positive end-expiratory
ressure (PEEP) was elevated to 3 cmH2O, and functional data
easurement repeated. Arterial blood (300 l) was drawn into a
eparinized syringe to determine arterial oxygen partial pressure & Neurobiology 203 (2014) 45–50
(PaO2) (i-STAT, Abbott Laboratories, Illinois, USA) (Baseline-PEEP).
Lung mechanics and PaO2 were measured after 1 h of mechanical
ventilation (End-PEEP). Animals were then euthanized and lungs
extracted for histological and molecular biology analysis.
2.2. Data acquisition and processing
Airﬂow, airway (P,aw), and esophageal pressures (Pes) were
continuously recorded throughout the experiments with a com-
puter running custom software written in LabVIEW® (National
Instruments; Austin, Texas, USA). Tidal volume (VT) was calcu-
lated by digital integration of the ﬂow signal. Transpulmonary
pressure (P,L) was  calculated during inspiration and expiration
as the difference between P,aw and Pes. All signals were ﬁl-
tered (200 Hz), ampliﬁed in a 4-channel signal conditioner (SC-24,
SCIREQ, Montreal, Quebec, Canada), and sampled at 200 Hz with a
12-bit analogue-to-digital converter (National Instruments; Austin,
Texas, USA). Static lung elastance (Est,L) and resistive pressure
(P1,L) were computed ofﬂine by a routine written in MATLAB
(Version R2007a; The Mathworks Inc, Natik, Massachusetts, USA)
(Santos et al., 2012).
2.3. Lung histology
A laparotomy was performed and heparin (1000 IU) injected
into the tail vein. The trachea was  clamped at PEEP = 3 cmH2O and
animals were euthanized by severing the abdominal aorta and vena
cava, producing massive hemorrhage and rapid death by exsan-
guination. Lungs were removed en bloc at the same PEEP level in
both groups to avoid distortion of lung morphometry. The right lung
was ﬁxed in 3% buffered formaldehyde and embedded in parafﬁn.
Slices (4 m thick) were cut and stained with hematoxylin-eosin.
Lung morphometry was  assessed with an integrating eyepiece
with a coherent system consisting of a grid with 100 points and 50
lines of known length coupled to a conventional light microscope
(OlympusBX51, Olympus Latin America-Inc., Brazil). The volume
fractions of the lung occupied by hyperinﬂated structures (alveolar
ducts, alveolar sacs, or alveoli wider than 120 m),  collapsed alveoli
(alveoli with rough or plicate walls), and normal pulmonary areas
(those not presenting overdistended or plicate walls) were deter-
mined by the point-counting technique at a magniﬁcation of ×200
across 10 random, noncoincident microscopic ﬁelds (Weibel, 1990).
To quantify interstitial edema, ﬁve arteries were transversely sec-
tioned. The number of points falling on areas of perivascular edema
and the number of intercepts between the lines of the integrat-
ing eyepiece and the basal membrane of the vessels were counted.
The interstitial perivascular edema index was calculated as follows:
number of points1/2/number of intercepts (Santiago et al., 2010).
2.4. Biological markers of pro-inﬂammatory and
anti-inﬂammatory activity, apoptosis, ﬁbrogenesis, oxidative
stress, and lung epithelial and endothelial cell damage
Quantitative real-time reverse transcription polymerase chain
reaction (PCR) was  performed to measure biological markers
associated with inﬂammation (interleukin [IL]-6 and IL-1),
and oxidative stress (inducible nitric oxide synthase [iNOS],
endothelial nitric-oxide synthase [eNOS], and nuclear factor
erythroid 2-related factor 2 [Nrf2]). Central slices of the left lung
were cut, collected in cryotubes, ﬂash-frozen by immersion in
liquid nitrogen, and stored at −80 ◦C. Total RNA was extracted
using the SV Total RNA Isolation System (Promega Corporation,
Fitchburg, Wisconsin, USA), following manufacturer recommen-
dations. RNA concentration was  measured by spectrophotometry
in Nanodrop ND-1000. First-strand cDNA was synthesized from
total RNA using the GoTaq® 2-STEP RT qPCR System (Promega
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Table  1
Lung morphometry.
C ALI
NV NV Thiopental sodium Dexmedetomidine Propofol
Normal (%) 97.4 ± 1.6 80.0 ± 5.8†  68.8 ± 6.1†  72.5 ± 7.6†  92.2 ± 2.6*#**
Collapse (%) 3.3 ± 1.6 20.0 ± 4.1†  17.8 ± 4.1†  21.4 ± 7.6†  8.7 ± 2.6*#**
Interstitial edema (dimensionless quantity) 0.0 ± 0.0 4.5 ± 1.3† 4.0 ± 1.2† 3.8 ± 1.3† 4.2 ± 1.4†
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ualues expressed as mean (±SD) of six (C-NV, ALI-NV) or eight (ALI-Thiopental, ALI
copic  ﬁelds were analyzed in each lung. Normal: volume fraction of the lung occup
,  control; ALI, acute lung injury; NV, non-ventilated. *Signiﬁcantly different from t
orporation, Fitchburg, Wisconsin, USA). The primers (Integrated
NA Technologies, San Diego, California, USA) used for gene
mpliﬁcation are listed in Table 1 (data online). All samples were
easured in triplicate. Relative gene expression was  calculated as a
atio of average gene expression levels to the reference gene (36B4)
nd expressed as fold changes relative to C-NV animals using the
−CT method, where CT = CT, reference gene – CT, target gene.
.5. Statistical analysis
Parametric data were expressed as mean ± standard deviation,
hereas nonparametric data were expressed as median (interquar-
ile range). One way ANOVA followed by Tukey’s test was  used
o compare lung morphometry and molecular biology data. The
ruskal–Wallis test followed by Dunn’s test was  used to compare
aO2 and lung mechanics among different anesthetic agents at
aseline-PEEP and End-PEEP. The Wilcoxon signed-rank test was
sed to compare PaO2 and lung mechanics between Baseline-PEEP
nd End-PEEP. All tests were performed using GraphPad Prism
5.00 (GraphPad Software, La Jolla, California, USA). Signiﬁcance
as established at p < 0.05.
. Results
There was no signiﬁcant difference in MAP  among groups and
o colloid solution was required to maintain MAP  ≥70 mmHg. From
aseline-PEEP to End-PEEP, PaO2 increased only in the dexmedeto-
idine group (Fig. 1), whereas Est,L and P1,L decreased in the
ropofol group (Fig. 1). At End-PEEP, P1,L was  lower in the
ropofol than in the dexmedetomidine group, with no signiﬁcant
ifference in Est,L among groups.
The fraction area of alveolar collapse was higher in ALI-NV than
n C-NV animals, but lower in the propofol than in the ALI-NV
nd dexmedetomidine groups (Table 1). The degree of interstitial
dema was similar in the ALI-NV, thiopental sodium, dexmedeto-
idine, and propofol groups. Lung hyperinﬂation and alveolar and
irway edema were not observed in ALI animals.
The mRNA expressions of IL-6 and IL-1 in lung tissue were
igher in ALI-NV than in C-NV animals, and lower in the propofol
roup than in the ALI-NV and thiopental sodium groups. IL-1
xpression was reduced to a greater extent in the propofol group
han in the ALI-NV, thiopental sodium, and dexmedetomidine
roups (Fig. 2). The mRNA expression of iNOS and eNOS was
ncreased in ALI-NV compared to C-NV animals. iNOS was  lower
n the dexmedetomidine group than in the thiopental sodium
nd propofol groups. eNOS was similar in the ALI-NV, thiopental
odium, dexmedetomidine, and propofol groups, whereas, Nrf2
xpression was increased only in the dexmedetomidine group
Fig. 3).. Discussion
In the model of mild ALI in mechanically ventilated rats
sed in this experiment, we found that short-term (1 h)edetomidine, ALI-Propofol) rats in each group. Ten random, noncoincident micro-
 normal alveoli. Collapse: volume fraction of the lung occupied by collapsed alveoli.
tal sodium (p < 0.05). #Signiﬁcantly different from propofol (p < 0.05).
intravenous administration of dexmedetomidine improved oxy-
genation, decreased iNOS, and increased Nrf2 mRNA expression,
whereas propofol decreased Est,L, P1,L, alveolar collapse, and IL-
6 and IL-1 mRNA expression in lung tissue. Therefore, propofol
and dexmedetomidine yielded different functional effects and led
to distinct biomarker expression patterns in this model.
Experimental mild ALI was  induced by intraperitoneal injec-
tion of E. coli LPS, leading to alveolar collapse, interstitial edema,
neutrophil inﬁltration, and impairment of lung mechanics (Riva
et al., 2008). A protective ventilation strategy with VT = 6 ml/kg and
PEEP = 3 cmH2O was employed to minimize the inﬂuence of pos-
sible confounding factors on lung function and molecular biology
data. Thiopental sodium was administered to all groups because
it is not known to affect the inﬂammatory process (Giraud et al.,
2000) or lung mechanics and morphometry (Correa et al., 2001).
The animals were not exposed to any nociceptive stimulus, except
for tracheotomy, which was performed under local anesthesia.
In our study, propofol led to a reduction in Est,L and P1,L
from Baseline-PEEP to END-PEEP. Accordingly, propofol has been
previously reported to improve respiratory mechanics in experi-
mental lung injury induced by hepatic ischemia-reperfusion in rats
(Chan et al., 2008) and in humans during extracorporeal circula-
tion (Schepp and Reutershan, 2008). Conversely, dexmedetomidine
showed no effects on respiratory mechanics. However, Kastner
et al. (2005) observed that dexmedetomidine led to a sustained
reduction in dynamic compliance and a signiﬁcant increase in air-
way resistance in sheep. These different effects may  be attributable
to differences in drug dose and infusion duration.
The improvement in Est,L and P1,L in the propofol group may
be explained by the presence of smaller fractional area of alveo-
lar collapse and bronchodilation, respectively. In this line, propofol
leads to bronchodilation in healthy rats (Peratoner et al., 2004).
The absence of lung morphological and mechanical improvement
after dexmedetomidine administration may be associated with an
alpha-2 effect on the pulmonary vasculature, yielding increased
blood pressure in pulmonary capillaries (Villela and Nascimento
Junior, 2003; Kastner et al., 2007).
Dexmedetomidine, but not propofol, improved oxygenation,
which was  not related to changes in alveolar collapse. This may
be explained by different hypoxic pulmonary vasoconstriction
(HPV) responses between dexmedetomidine and propofol. Beck
et al. (2001) found that propofol has a weak inﬂuence on HPV,
whereas Pueyo et al. (1994) reported that, in mechanically ven-
tilated patients undergoing thoracic surgery, continuous infusion
of propofol signiﬁcantly increased shunt and decreased PaO2.
Conversely, alpha-2 agonists improved oxygenation in dogs under-
going single-lung ventilation, suggesting HPV optimization (Lubbe
et al., 1991). Therefore, it is likely that HPV was less affected by
dexmedetomidine than by propofol, resulting in a higher PaO2.
Two  inﬂammatory pathways were investigated to evaluate the
mechanisms of action of dexmedetomidine and propofol in this
experimental study. The ﬁrst pathway is associated with the inhibi-
tion of signaling by NF-kappaB, modulating pro-inﬂammatory and
anti-inﬂammatory mediators. In our study, a 1-h propofol infusion
reduced expression of the pro-inﬂammatory cytokines IL-6 and
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Fig. 1. Arterial blood partial pressure oxygen (upper panel), static lung elastance
(Est,L) (middle panel), and lung resistive pressure (P1,L) (lower panel) at Baseline-
positive end-expiratory pressure (PEEP) and End-PEEP in ALI animals anesthetized
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Fig. 2. Real-time reverse transcription polymerase chain reaction analysis of pro-
inﬂammatory biological markers—interleukin (IL)-6 (upper panel) and IL-1 (lower
panel). C, control; ALI, acute lung injury; NV, non-ventilated. Relative gene expres-
sion was calculated as the ratio of average gene expression levels compared with
the  reference gene (36B4) and expressed as fold changes relative to controls (ani-
mals treated with saline, anesthetized with sodium thiopental, and not ventilated
mechanically). Data are presented as mean + SD of six animals in each group.
*Signiﬁcantly different from the thiopental sodium group (p < 0.05). †  Signiﬁcantly
**
led to a reduction in iNOS compared to ALI-NV, but no signiﬁcantith thiopental sodium (gray bar), dexmedetomidine (white bar), and propofol
dark gray bar). *Signiﬁcantly different from thiopental sodium (p < 0.05). #Signiﬁ-
antly different from dexmedetomidine (p < 0.05).
L-1, which is consistent with previous studies (Kwak et al., 2004;
ang et al., 2011). On the other hand, we found that dexmedeto-
idine did not inﬂuence the up-regulation of endotoxin-induced
ulmonary inﬂammatory mediators. This stands in contrast with
he ﬁndings of previous studies (Yang et al., 2009, 2011, 2008) thatdifferent from the C-NV group (p < 0.05). Signiﬁcantly different from the ALI-NV
group (p < 0.05). #Signiﬁcantly different from the dexmedetomidine group (p < 0.05).
showed an anti-inﬂammatory effect of dexmedetomidine. The
following factors may  explain the differences between our study
and those reported previously: (1) combination of dexmedeto-
midine with other anesthetic agents (Yang et al., 2009, 2011);
(2) administration of higher doses, before or immediately after
lung damage induction (Jiang et al., 2014); (3) longer duration of
infusion (Chen et al., 2008); and (4) use of different models of lung
injury (Jiang et al., 2014).
The second pathway is associated with mechanisms related
to oxidative stress. In this line, the transcription factor Nrf2,
the antioxidant enzyme iNOS, and the constitutive NOS isoform
expressed mainly in endothelial cells (eNOS) were measured.
Nrf2 regulates antioxidant defenses that protect against inﬂam-
mation by inhibiting oxidative tissue injury (Cho et al., 2006;
Kong et al., 2011). To our knowledge, the inﬂuence of propo-
fol, dexmedetomidine, and thiopental sodium on Nrf2 expression
in acute lung inﬂammation has not been investigated. We  found
that dexmedetomidine increased Nrf2 expression in lung tissue
as compared with the other agents tested, suggesting its pos-
sible role in reducing lung inﬂammation. iNOS is expressed in
various types of lung cells in response to pathogens (Dias-Junior
et al., 2008). In ALI-NV animals, both iNOS and eNOS expression
were increased as compared with C-NV animals, which is con-
sistent with previous studies (Farley et al., 2006; Lange et al.,
2010; Razavi et al., 2004). iNOS expression was reduced in the
dexmedetomidine group compared to the ALI-NV and thiopental
sodium groups, which may  be attributed to the high dose used
in the present study to keep animals pain-free and relaxed. In
this context, a previous study showed a dose-dependent action of
dexmedetomidine on oxidative stress (Yang et al., 2008). Propofoldecrease was  observed in iNOS compared to the thiopental sodium
group; again, this is consistent with previous studies (Chen et al.,
2008). There were no signiﬁcant differences in eNOS expression
V. Cavalcanti et al. / Respiratory Physiology & Neurobiology 203 (2014) 45–50 49
Fig. 3. Real-time reverse transcription polymerase chain reaction analysis of biological markers associated with oxidative stress: nuclear factor erythroid 2-related factor 2
(Nrf2),  inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS). C, control; ALI, acute lung injury; NV, non-ventilated. Relative gene expression
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aas  calculated as the ratio of average gene expression levels compared with the re
ith  saline, anesthetized with sodium thiopental, and not mechanically ventilated
rom  the thiopental sodium group (p < 0.05). †  Signiﬁcantly different from the C-NV
cross the thiopental sodium, propofol, dexmedetomidine, and ALI-
V groups. However, a previous study (Gao et al., 2006) found
hat propofol reduced eNOS mRNA expression. This difference
ay  be related to: (1) distinct propofol infusion protocols; (2)
ifferent observation time; and (3) timing of propofol infusion
in most studies, the infusion is started before induction of lung
njury).
Dexmedetomidine and propofol are commonly used for short-
erm anesthesia and procedural sedation in patients with acute
ung injury. Our data suggest that, in an animal model of
ild ALI, both dexmedetomidine and propofol reduced bio-
ogical markers of inﬂammation in lung tissue. However, due
o their different functional effects, dexmedetomidine might
e indicated in patients with hypoxemia, whereas propofol
ight be better suited in patients with clinical bronchoconstric-
ion.
The present study has some limitations. Our results can-
ot be extrapolated to other experimental models of ALI, with
ifferent severities and ventilator strategies, or to the clini-
al setting. The observation time was relatively short (1 h of
echanical ventilation), precluding extrapolation of our ﬁndings
o longer periods of ventilation. The expression of mediators
as quantiﬁed using RT-PCR instead of ELISA. It is well known
hat 1 h is sufﬁcient time to produce changes in mRNA expres-
ion, but not to signiﬁcantly change protein levels (Vogel and
arcotte, 2012). The dose of dexmedetomidine used in the present
tudy was higher than that commonly used in clinical practice.
owever, the pharmacokinetics of this agent differ in rats and
umans due to rapid metabolism (Bol et al., 1997; Villela and
ascimento Junior, 2003), and our aim was to keep the animals
nesthetized.ce gene (36B4) and expressed as fold changes relative to controls (animals treated
a are presented as mean + SD of six animals in each group. *Signiﬁcantly different
 (p < 0.05). **Signiﬁcantly different from the ALI-NV group (p < 0.05).
5. Conclusions
In the model of mild ALI used herein, short-term administra-
tion of dexmedetomidine and propofol led to different functional
effects and activation of biological markers associated with pul-
monary inﬂammation. The present study may be considered as a
ﬁrst step for developing other experimental and clinical studies to
evaluate the short-term effects of propofol and dexmedetomidine
in ALI.
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